American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Preferred Bank
PFBC
$1.26B
| $6.98M | 0.01% |
112,126
+23,032
| +26% | +$1.44M |
|
1202
10x Genomics
TXG
$7.52B
| $6.97M | 0.01% |
168,997
-458
| -0.3% | -$23.8K |
|
1203
Peoples Bancorp
PEBO
$1.48B
| $6.94M | 0.01% |
273,435
+35,603
| +15% | +$946K |
|
|
TBI
1204
Trueblue
TBI
$302M
| $6.94M | 0.01% |
473,011
+53,517
| +13% | +$834K |
|
|
SWN
1205
DELISTED
Southwestern Energy Company
SWN
| $6.92M | 0.01% |
1,073,641
+234,132
| +28% | +$1.49M |
|
1206
Eagle Bancorp
EGBN
$877M
| $6.92M | 0.01% |
322,662
+28,384
| +10% | +$690K |
|
1207
3M
MMM
$94.8B
| $6.92M | 0.01% |
88,350
+6,199
| +8% | +$532K |
|
1208
Super Micro Computer
SMCI
$25.3B
| $6.91M | 0.01% |
251,910
+34,190
| +16% | +$953K |
|
1209
Klaviyo
KVYO
$5.47B
| $6.9M | 0.01% |
+200,000
| New | +$6.86M |
|
1210
KeyCorp
KEY
$24.5B
| $6.89M | 0.01% |
640,787
+78,773
| +14% | +$872K |
|
1211
Dr. Reddy's Laboratories
RDY
$10.3B
| $6.85M | 0.01% |
512,485
+59,650
| +13% | +$807K |
|
1212
Canadian Imperial Bank of Commerce
CM
$110B
| $6.85M | 0.01% |
177,501
+14,141
| +9% | +$584K |
|
1213
Fulgent Genetics
FLGT
$515M
| $6.85M | 0.01% |
256,210
-16,061
| -6% | -$548K |
|
1214
Keros Therapeutics
KROS
$222M
| $6.82M | 0.01% |
214,074
+71
| +0% | +$2.65K |
|
1215
RPC Inc
RES
$1.4B
| $6.81M | 0.01% |
761,195
+222,888
| +41% | +$1.86M |
|
1216
Forestar Group
FOR
$1.49B
| $6.78M | 0.01% |
251,728
+15,137
| +6% | +$417K |
|
1217
Center Bancorp
CNOB
$1.81B
| $6.77M | 0.01% |
379,804
-716,747
| -65% | -$13.4M |
|
|
WRK
1218
DELISTED
WestRock Company
WRK
| $6.76M | 0.01% |
188,935
+54,914
| +41% | +$1.8M |
|
1219
Harmony Biosciences
HRMY
$2.32B
| $6.74M | 0.01% |
205,609
-267,431
| -57% | -$9.28M |
|
1220
Avantis Real Estate ETF
AVRE
$871M
| $6.72M | 0.01% |
178,995
+44,901
| +33% | +$1.82M |
|
|
CERE
1221
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $6.72M | 0.01% |
307,743
-1,504
| -0.5% | -$37.6K |
|
|
CHUY
1222
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $6.7M | 0.01% |
188,366
-6,414
| -3% | -$246K |
|
1223
Carnival Corporation Ltd
CCL
$38.9B
| $6.69M | 0.01% |
487,635
+344,947
| +242% | +$5.72M |
|
1224
Clorox
CLX
$12.8B
| $6.67M | 0.01% |
50,913
-6,479
| -11% | -$985K |
|
1225
Health Catalyst
HCAT
$135M
| $6.65M | 0.01% |
657,552
+62,010
| +10% | +$740K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.